The blood–brain barrier: structure, regulation, and drug delivery
Blood–brain barrier (BBB) is a natural protective membrane that prevents central nervous
system (CNS) from toxins and pathogens in blood. However, the presence of BBB …
system (CNS) from toxins and pathogens in blood. However, the presence of BBB …
Engineered exosomes from different sources for cancer-targeted therapy
M Zhang, S Hu, L Liu, P Dang, Y Liu, Z Sun… - Signal transduction and …, 2023 - nature.com
Exosome is a subgroup of extracellular vesicles, which has been serving as an efficient
therapeutic tool for various diseases. Engineered exosomes are the sort of exosomes …
therapeutic tool for various diseases. Engineered exosomes are the sort of exosomes …
Neutrophil-like cell-membrane-coated nanozyme therapy for ischemic brain damage and long-term neurological functional recovery
L Feng, C Dou, Y Xia, B Li, M Zhao, P Yu, Y Zheng… - ACS …, 2021 - ACS Publications
Oxidative stress and a series of excessive inflammatory responses are major obstacles for
neurological functional recovery after ischemic stroke. Effective noninvasive anti …
neurological functional recovery after ischemic stroke. Effective noninvasive anti …
Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches
K Mitusova, OO Peltek, TE Karpov… - Journal of …, 2022 - Springer
Besides the broad development of nanotechnological approaches for cancer diagnosis and
therapy, currently, there is no significant progress in the treatment of different types of brain …
therapy, currently, there is no significant progress in the treatment of different types of brain …
Tumor–antigen activated dendritic cell membrane-coated biomimetic nanoparticles with orchestrating immune responses promote therapeutic efficacy against glioma
X Ma, L Kuang, Y Yin, L Tang, Y Zhang, Q Fan… - ACS …, 2023 - ACS Publications
Immunotherapy has had a profound positive effect on certain types of cancer but has not
improved the outcomes of glioma because of the blood–brain barrier (BBB) and …
improved the outcomes of glioma because of the blood–brain barrier (BBB) and …
Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation
The past few decades have witnessed an evolution of nanomedicine from biologically inert
entities to more smart systems, aimed at advancing in vivo functionality. However, we should …
entities to more smart systems, aimed at advancing in vivo functionality. However, we should …
Meningeal lymphatic vessels regulate brain tumor drainage and immunity
Recent studies have shown that meningeal lymphatic vessels (MLVs), which are located
both dorsally and basally beneath the skull, provide a route for draining macromolecules …
both dorsally and basally beneath the skull, provide a route for draining macromolecules …
A Cholesterol Metabolic Regulated Hydrogen‐Bonded Organic Framework (HOF)‐Based Biotuner for Antibody Non‐Dependent Immunotherapy Tailored for …
N Yin, Y Wang, Y Liu, R Niu, S Zhang, Y Cao… - Advanced …, 2023 - Wiley Online Library
The metabolic reprogramming of glioblastoma (GBM) poses a tremendous obstacle to
effective immunotherapy due to its impact on the immunosuppressive microenvironment. In …
effective immunotherapy due to its impact on the immunosuppressive microenvironment. In …
Advances in nanomaterial-based targeted drug delivery systems
X Cheng, Q Xie, Y Sun - Frontiers in bioengineering and …, 2023 - frontiersin.org
Nanomaterial-based drug delivery systems (NBDDS) are widely used to improve the safety
and therapeutic efficacy of encapsulated drugs due to their unique physicochemical and …
and therapeutic efficacy of encapsulated drugs due to their unique physicochemical and …
Immune checkpoint inhibition in GBM primed with radiation by engineered extracellular vesicles
The lack of safe and effective delivery across the blood-brain barrier and the profound
immune suppressive microenvironment are two main hurdles to glioblastoma (GBM) …
immune suppressive microenvironment are two main hurdles to glioblastoma (GBM) …